BCR and diffuse large B-cell lymphoma: Accordingly, these SHP-1 negative lines showed increased levels of phosphorylated SYK and BLNK which were reduced by SHP-1 re-expression, providing direct evidence that SHP1 deficiency is at least in part responsible for the constitutive activation of the BCR pathway in GCB DLBCL [26].